🇪🇺 TachoSil in European Union

EMA authorised TachoSil on 8 June 2004

Marketing authorisation

EMA — authorised 8 June 2004

  • Application: EMEA/H/C/000505
  • Marketing authorisation holder: Corza Medical GmbH
  • Local brand name: TachoSil
  • Indication: TachoSil is indicated in adults and children from 1 month of age for supportive treatment in surgery for improvement of haemostasis, to promote tissue sealing and for suture support in vascular surgery where standard techniques are insufficient. TachoSil is indicated in adults for supportive sealing of the dura mater to prevent postoperative cerebrospinal leakage following neurological surgery (see section 5.1).
  • Status: approved

Read official source →

Other Surgery / Hemostasis approved in European Union

Frequently asked questions

Is TachoSil approved in European Union?

Yes. EMA authorised it on 8 June 2004.

Who is the marketing authorisation holder for TachoSil in European Union?

Corza Medical GmbH holds the EU marketing authorisation.